Crossmark

miR-26a inhibits atherosclerosis progression by targeting TRPC3

Crossref DOI link: https://doi.org/10.1186/S13578-018-0203-9

Published: 2018-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Feng, Min

Xu, Daqian

Wang, Lirui
More Information

Article History

Received: 10 October 2017

Accepted: 6 January 2018

First Online: 19 January 2018